Change theme to redChange theme to blueChange theme to greenChoose your color
Last Modified Date: 17 Jan 2013
  • |
  • Printer Friendly
  • |
  • Download Adobe Reader
  • |
  • Small Font
  • Medium Font
  • Large Font
Marketing Materials
 
 
Home
Technologies Available for Licensing

Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at USAMRMCORTA@amedd.army.mil


RECOMBINANT VACCINE AGAINST BOTULINUM NEUROTOXIN

This invention is directed to preparation and expression of synthetic genes encoding polypeptides containing protective epitopes of botulinum neurotoxin (BoNT). The invention is also directed to production of immunogenic peptides encoded by the synthetic genes, as weel as recovery and purification of the immunogenic peptides from recombinant organisms. The invention is also directed to methods of vaccination against botulism using the expressed peptides.

Number:7,214,787

Date:2007-05-08

Type: Issued

Category: Method

More Detail:Visit USPTO.GOVExternal link

Lab:RIID

Inventor(s):SMITH, L.; BYRNE, M.; MIDDLEBROOK, J.; LAPENTIERE, H.; CLAYTON, M.; BROWN, D.

For Licensing Opportunities, please contact the ORTA at USAMRMCORTA@amedd.army.mil
 
 

iSalute

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRMC Public Affairs Office at:
usamrmcwebmaster@amedd.army.mil or by telephone at (301)619-2736